Roundup
Connecting the firms with individuals suffering from Non-Hodgkin's Lymphoma after exposure to glyphosate-based herbicides.
Case Overview
Roundup, the world's most popular weed killer, contains glyphosate, a chemical that the World Health Organization classified as a 'probable human carcinogen' in 2015.
Tens of thousands of lawsuits have been filed against Monsanto (now Bayer) alleging that exposure to Roundup caused plaintiffs to develop Non-Hodgkin's Lymphoma and that the company failed to warn consumers of this risk.
Despite billions in settlements several past, new cases continue to emerge as long-term users develop health conditions.
This directly correlates with significant exposure history and specific cancer diagnoses.
The primary link established in litigation is between glyphosate and lymphatic cancers.
The most common cancer linked to Roundup: A cancer that starts in white blood cells called lymphocytes.
A type of cancer of the blood and bone marrow that affects lymphocytes. Often considered a form of NHL.
Various subtypes of B-cell lymphomas have been associated with glyphosate exposure in studies and litigation.
We find high-value Roundup cases by targeting individuals with significant exposure history.
We target landscapers, farmers, and groundskeepers who have had highest exposure levels and strongest cases.
We follow trends within the Quantity and Frequency of use to ensure cases meet settlement criteria.
We have successfully generated thousands of qualified Roundup leads for firms across the country.
Key Facts
- Product: Roundup Weed Killer
- Active Ingredient: Glyphosate
- Primary Injury: Non-Hodgkin's Lymphoma (NHL)
- Litigation Status: Active - Ongoing Settlements & Trials
Who Qualifies
Exposure History
- Residential use (home gardener/lawn care)
- Commercial use (landscapers, farmers, groundskeepers)
- Significant frequency of use
- Direct exposure (mixing, spraying, contact)
Medical Diagnosis
- Non-Hodgkin's Lymphoma (NHL)
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Lymphoma (SLL)
- Mantle Cell Lymphoma
Timing
- Diagnosis after significant exposure
- Latency period considered (time between exposure and diagnosis)
Exclusions
- Other types of cancers not linked to glyphosate
- Minimal or incidental exposure
- Diagnosis prior to Roundup use
Linked Conditions
Non-Hodgkin's Lymphoma
The most common cancer linked to Roundup: A cancer that starts in white blood cells called lymphocytes.
Chronic Lymphocytic Leukemia
A type of cancer of the blood and bone marrow that affects lymphocytes. Often considered a form of NHL.
B-Cell Lymphomas
Various subtypes of B-cell lymphomas have been associated with glyphosate exposure in studies and litigation.
Interested in This Case?
Let's discuss how we can help you acquire qualified leads for this mass tort campaign.